Approval · Notice of Compliance 12376 · 2011
BRILINTA: Notice of Compliance 12376
Issued May 30, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12376
- Date
- May 30, 2011
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Platelet aggregation inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BRILINTA | 02368544 | Marketed |
Medicinal ingredients
- TICAGRELOR 90 MG per TAB